FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
ofatumumab 100 mg/5 mL injection, vial
ofatumumab 20 mg/0.4 mL injection, pen device
ofatumumab 20 mg/0.4 mL injection, syringe
ofloxacin 0.3% eye drops
olanzapine (as pamoate) 210 mg modified release injection, vial
olanzapine (as pamoate) 300 mg modified release injection, vial
olanzapine (as pamoate) 405 mg modified release injection, vial
olanzapine 10 mg injection, vial
olanzapine 10 mg orally disintegrating tablet
olanzapine 10 mg tablet
olanzapine 10 mg wafer
olanzapine 15 mg orally disintegrating tablet
olanzapine 15 mg tablet
olanzapine 15 mg wafer
olanzapine 2.5 mg tablet
olanzapine 20 mg orally disintegrating tablet
olanzapine 20 mg tablet
olanzapine 20 mg wafer
olanzapine 5 mg orally disintegrating tablet
olanzapine 5 mg tablet
olanzapine 5 mg wafer
olanzapine 7.5 mg tablet
olaparib 100 mg tablet
olaparib 150 mg tablet
olaparib 50 mg capsule
olive oil
olive oil 16 g/100 mL + soya oil 4 g/100 mL injection, bag
olive oil 16 g/100 mL + soya oil 4 g/100 mL injection, bottle
olive oil 160 g/L + soya oil 40 g/L injection, bottle
olive oil 24 g/L + soya oil 6 g/L injection, chamber
olive oil 40 g/250 mL + soya oil 10 g/250 mL injection, bag
olive oil 40 g/250 mL + soya oil 10 g/250 mL injection, bottle
olive oil 56 g/350 mL + soya oil 14 g/350 mL injection, bag
olive oil 80 g/500 mL + soya oil 20 g/500 mL injection, bag
olive oil 80 g/500 mL + soya oil 20 g/500 mL injection, bottle
olmesartan medoxomil 10 mg tablet
olmesartan medoxomil 20 mg tablet
olmesartan medoxomil 40 mg tablet
olodaterol 2.5 microgram / 1 actuation + tiotropium 2.5 microgram / 1 actuation inhalation solution, actuation (medicinal product unit of use)
olodaterol 2.5 microgram/actuation inhalation solution, actuation
olopatadine 0.1% eye drops
olsalazine sodium 250 mg capsule
olsalazine sodium 500 mg tablet
omalizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use)
omalizumab 150 mg injection, 150 mg vial (medicinal product unit of use)
omalizumab 75 mg / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use)
omalizumab 75 mg injection, vial
paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet
omega-3-acid ethyl esters-90 1 g capsule
omeprazole 10 mg enteric tablet
omeprazole 20 mg enteric capsule
omeprazole 20 mg enteric tablet
omeprazole 40 mg enteric tablet
omeprazole 40 mg injection, vial
onasemnogene abeparvovec 20 trillion vector genomes/mL injection, 5.5 mL vial
onasemnogene abeparvovec 20 trillion vector genomes/mL injection, 8.3 mL vial
ondansetron 16 mg suppository
ondansetron 24 mg tablet
ondansetron 4 mg/2 mL injection, ampoule
ondansetron 4 mg/2 mL injection, syringe
ondansetron 4 mg/2 mL injection, vial
ondansetron 4 mg/5 mL oral liquid
ondansetron 4 mg orally disintegrating tablet
ondansetron 4 mg tablet
ondansetron 4 mg wafer
ondansetron 8 mg/4 mL injection, ampoule
ondansetron 8 mg/4 mL injection, syringe
ondansetron 8 mg / 4 mL injection, 4 mL vial (medicinal product unit of use)
ondansetron 8 mg orally disintegrating tablet
ondansetron 8 mg tablet
ondansetron 8 mg wafer
opicapone 50 mg capsule
orlistat 120 mg capsule
orlistat 60 mg capsule
ornipressin 5 units/mL injection, ampoule
orphenadrine citrate 100 mg modified release tablet
orphenadrine citrate 35 mg + paracetamol 450 mg tablet
oryza sativa 6 g + sodium citrate dihydrate 580 mg + sodium chloride 350 mg + potassium chloride 300 mg (potassium 4 mmol) powder for oral liquid, 7.5 g sachet
oseltamivir 12 mg/mL powder for oral liquid
oseltamivir 30 mg capsule
oseltamivir 45 mg capsule
oseltamivir 6 mg/mL powder for oral liquid
oseltamivir 75 mg capsule
osilodrostat 1 mg tablet
osilodrostat 10 mg tablet
osilodrostat 5 mg tablet
osimertinib 40 mg tablet
osimertinib 80 mg tablet
osteogenic protein-1 3.3 mg implant, vial
oxaliplatin 100 mg/20 mL injection, vial
oxaliplatin 100 mg injection, vial
oxaliplatin 150 mg injection, vial
oxaliplatin 20 mg injection, vial
oxaliplatin 200 mg/40 mL injection, vial
oxaliplatin 50 mg/10 mL injection, vial
oxaliplatin 50 mg injection, vial
oxazepam 15 mg tablet
oxazepam 30 mg tablet
oxcarbazepine 150 mg tablet
oxcarbazepine 300 mg tablet
oxcarbazepine 60 mg/mL oral liquid

Start Previous Page 57 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start